Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06728683 · ClinicalTrials.gov registry record · NA
Assist MH Digital Technologies to Support School Mental Health Care
A NA study of Mental Health Strategies and School Mental Health Services, sponsored by 3-C Institute for Social Development.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 1
- Study location
NCT06728683: Completed NA study of Mental Health Strategies and School Mental Health Services, sponsored by 3-C Institute for Social Development.
NCT06728683 is a NA study of Mental Health Strategies and School Mental Health Services that has completed, run by 3-C Institute for Social Development. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06728683, a NA study of Mental Health Strategies and School Mental Health Services, has completed, sponsored by 3-C Institute for Social Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this SBIR is to develop and test Assist-MH, a new interactive digital support system for SMH providers. Assist-MH will offer SMH treatment resources to help providers implement a more customized treatment plan specific to the student's needs. Based on student areas of need, the system will deliver both provider-led MH strategies to optimize time spent with the student and self-paced digital strategies (video, game-based, interactive) for students to augment in-person treatment and provide unique between-session learning and practice.
Primary Outcome
Providers will rate their experiences with the prototype. Ratings will be made on a 5-pt scale (1=Strongly Disagree to 5=Strongly Agree) to assess each component and the overall prototype in each of the following areas: usability (e.g., user friendly, easy to navigate, engaging), feasibility (e.g., time efficient, doable), and value (e.g., quality, innovation, effectiveness for intended purpose). The 24 items will be computed into a summary score ranging from 1-5 to reflect mean ratings. A highe
Conditions Studied
Interventions
- OTHER ASSIST-MH
Study Locations (1)
North Carolina
- 3-C Institute for Social Development, Inc - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2025-07-18 |
| Phase | NA |
What the finished NCT06728683 record still lists
NCT06728683 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 4 conditions, with Mental Health Strategies appearing as the primary indexed condition, and to 1 intervention - of which ASSIST-MH is the first listed.
NCT06728683 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06728683 about?
NCT06728683 is a clinical study titled "Assist MH Digital Technologies to Support School Mental Health Care". The goal of this SBIR is to develop and test Assist-MH, a new interactive digital support system for SMH providers. Assist-MH will offer SMH treatment resources to help providers implement a more customized treatment plan specific to the student's needs. Based on student areas of need, the system wi...
What is the current status of trial NCT06728683?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2025-04-01. Estimated completion is 2025-07-18.
What conditions does trial NCT06728683 study?
This clinical trial studies the following conditions: Mental Health Strategies, School Mental Health Services, Digital Technologies, Technology Development.
What interventions are being tested in trial NCT06728683?
The interventions under investigation include: ASSIST-MH (OTHER).
Who is sponsoring clinical trial NCT06728683?
This trial is sponsored by 3-C Institute for Social Development, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06728683 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06728683's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI